Pertussis

New Testing Standards Needed for Combination Vaccines

Published in Vaccine Weekly, December 9th, 1996

The growing number of vaccines and vaccine combinations will overwhelm the financial and technical resources available for thorough efficacy testing.

This situation likely will require postmarketing surveillance to collect data formerly provided by large-scale trials, predict Pierre Begue and Emmanuel Grimprel of the Armand-Trousseau Children's Infectious and Tropical Disease Hospital, Paris, France.

Begue and Grimprel considered the implications of new vaccine combinations in The Journal of Infectious Diseases ("Future Combined Vaccines," JID, 174(Suppl 3):S295-7).

"Because of the growing number of new vaccines to be included in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry